STOCK TITAN

Jonathan D. Schwartz Files Form 144 to Sell 11,161 RCKT Shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for proposed sale of common stock tied to restricted stock vesting. The filing shows 11,161 shares of Common stock to be sold through Fidelity Brokerage Services LLC on 08/14/2025 with an aggregate market value of $33,691.71. The shares were acquired on 08/12/2025 as Restricted Stock Vesting and paid as Compensation. The filer who sold shares in the past three months is identified as Jonathan D. Schwartz, with two prior sales on 05/16/2025 (1,582 shares for $10,326.51) and 05/20/2025 (801 shares for $5,163.25). The filing lists the issuer-related fields but does not provide the issuer name or address in the supplied content.

The filing also reports 107,903,871 shares outstanding, which makes the proposed sale approximately 0.0103% of outstanding shares based on provided figures.

Positive

  • Clear disclosure of acquisition date, nature (Restricted Stock Vesting), and payment as Compensation
  • Broker and execution date are specified (Fidelity Brokerage Services LLC; 08/14/2025)
  • Prior insider sales in the past three months are listed with dates and gross proceeds, supporting transparency

Negative

  • Issuer name and address are not provided in the supplied content, limiting completeness of the filing as presented
  • Filing does not state whether a trading plan (Rule 10b5-1) applies, beyond the general representation

Insights

TL;DR: Small executive share sale from recently vested restricted stock; negligible dilution versus total shares outstanding.

The filing documents a proposed sale of 11,161 shares arising from restricted stock vesting and designated as compensation, to be executed via Fidelity on 08/14/2025. Given the stated 107,903,871 shares outstanding, the stake equals roughly 0.0103% of the outstanding base, indicating limited market impact. Prior insider sales totaling 2,383 shares in May generated $15,489.76 gross proceeds. This is a routine liquidity event commonly seen when restricted awards vest and does not, on its face, indicate material corporate change.

TL;DR: Disclosure shows compliance with Rule 144 procedures for sale of vested restricted shares; no material governance signal apparent.

The notice identifies the seller as Jonathan D. Schwartz and affirms the standard representation about material nonpublic information. The transaction type and timing—vesting on 08/12/2025 and proposed sale on 08/14/2025—are explicitly disclosed. The filing lacks the issuer name in the provided content, which should be included in a complete Form 144; otherwise the document follows expected disclosure for insider sales tied to compensation vesting.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed by Jonathan D. Schwartz for RCKT report?

The Form 144 reports a proposed sale of 11,161 shares of Common stock to be executed on 08/14/2025 through Fidelity, with aggregate market value $33,691.71.

Why were the 11,161 RCKT shares acquired and when?

The shares were acquired on 08/12/2025 through Restricted Stock Vesting and the consideration is listed as Compensation.

How much of RCKT's outstanding stock does the proposed sale represent?

Based on the filing's figures (11,161 shares vs 107,903,871 outstanding), the sale represents approximately 0.0103% of outstanding shares.

Has Jonathan D. Schwartz sold any RCKT shares recently?

Yes; the filing lists sales of 1,582 shares on 05/16/2025 for $10,326.51 and 801 shares on 05/20/2025 for $5,163.25.

Does the filing disclose the issuer name for this Form 144?

No; the provided content includes issuer-related fields but does not supply the issuer name or address in the supplied text.
Rocket Pharmaceu

NASDAQ:RCKT

RCKT Rankings

RCKT Latest News

RCKT Latest SEC Filings

RCKT Stock Data

370.12M
104.03M
3.27%
90.63%
14.35%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK